NASDAQ:ABIO

ARCA biopharma Stock Forecast, Price & News

$4.45

-0.03 (-0.67 %)

(As of 01/15/2021 12:00 AM ET)

Add

Compare

Today's Range

$4.41

Now: $4.45▼

$4.55

50-Day Range

$4.00

MA: $4.21▼

$4.55

52-Week Range

$2.21

Now: $4.45▼

$22.00

Volume278,821 shs

Average Volume538,660 shs

Market Capitalization$41.47 million

P/E RatioN/A

Dividend YieldN/A

Beta2.81

ARCA biopharma, Inc. operates as a biopharmaceutical company applying a precision medicine approach to developing and commercializing genetically targeted therapies for cardiovascular diseases. Its lead product candidate, Gencaro (bucindolol hydrochloride) is pharmacogenetically-targeted beta-adrenergic receptor antagonist, which is in the development for the treatment of atrial fibrillation in certain patients who also have heart failure (HF). The company also engages in the development of AB171, a thiol-substituted isosorbide mononitrate for the treatment of HF and peripheral arterial disease. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.

Overall MarketRank^™

0.90 out of 5 stars

Medical Sector

904th out of 1,556 stocks

Diagnostic Substances Industry

19th out of 28 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for ARCA biopharma.

2.2 Community Rank

Outperform Votes
ARCA biopharma has received 123 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
ARCA biopharma has received 154 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
ARCA biopharma has received 55.60% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about ARCA biopharma and other stocks. Vote “Outperform” if you believe ABIO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ABIO will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
ARCA biopharma does not currently pay a dividend.
Dividend Growth
ARCA biopharma does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ARCA biopharma insiders have bought more of their company's stock than they have sold. Specifically, they have bought $41,600.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 0.53% of the stock of ARCA biopharma is held by insiders.
Percentage Held by Institutions
Only 4.42% of the stock of ARCA biopharma is held by institutions.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of ARCA biopharma is -1.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of ARCA biopharma is -1.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
ARCA biopharma has a P/B Ratio of 0.93. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Diagnostic substances

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:ABIO

Previous Symbol

CUSIPN/A

CIK907654

Webarcabio.com

Phone720-940-2200

Employees13

Debt

Debt-to-Equity RatioN/A

Current Ratio34.01

Quick Ratio34.01

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book Value$4.77 per share

Price / Book0.93

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-5,480,000.00

Net MarginsN/A

Return on Equity-31.28%

Return on Assets-29.34%

Miscellaneous

Outstanding Shares9,320,000

Market Cap$41.47 million

Next Earnings Date2/16/2021 (Estimated)

OptionableNot Optionable

$4.45

-0.03 (-0.67 %)

(As of 01/15/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive ABIO News and Ratings via Email

Sign-up to receive the latest news and ratings for ABIO and its competitors with MarketBeat's FREE daily newsletter.

ARCA biopharma (NASDAQ:ABIO) Frequently Asked Questions

How has ARCA biopharma's stock been impacted by Coronavirus (COVID-19)?

ARCA biopharma's stock was trading at $3.36 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ABIO stock has increased by 32.4% and is now trading at $4.45.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than ARCA biopharma?

Wall Street analysts have given ARCA biopharma a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but ARCA biopharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is ARCA biopharma's next earnings date?

ARCA biopharma is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021.
View our earnings forecast for ARCA biopharma.

How were ARCA biopharma's earnings last quarter?

ARCA biopharma, Inc. (NASDAQ:ABIO) released its earnings results on Monday, November, 2nd. The biopharmaceutical company reported ($0.33) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($2.51) by $2.18.
View ARCA biopharma's earnings history.

Are investors shorting ARCA biopharma?

ARCA biopharma saw a decline in short interest in December. As of December 31st, there was short interest totaling 41,100 shares, a decline of 17.5% from the December 15th total of 49,800 shares. Based on an average trading volume of 539,500 shares, the short-interest ratio is presently 0.1 days.
View ARCA biopharma's Short Interest.

Who are some of ARCA biopharma's key competitors?

Some companies that are related to ARCA biopharma include Trinity Biotech (TRIB), Biomerica (BMRA), Navidea Biopharmaceuticals (NAVB), ImmuCell (ICCC), StageZero Life Sciences (GNWSF), Achieve Life Sciences (ACHV), StageZero Life Sciences (GNWSD), Akers Biosciences (AKER), Response Genetics (RGDXQ), BG Medicine (BGMD), FluoroPharma Medical (FPMI), Fuse Science (DROP) and Hemagen Diagnostics (HMGN).
View all of ABIO's competitors.

What other stocks do shareholders of ARCA biopharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ARCA biopharma investors own include Aurora Cannabis (ACBFF), MannKind (MNKD), Bausch Health Companies (BHC), Biocept (BIOC), Novavax (NVAX), AVEO Pharmaceuticals (AVEO), Gilead Sciences (GILD), iBio (IBIO), Nabriva Therapeutics (NBRV) and Synergy Pharmaceuticals (SGYP).

Who are ARCA biopharma's key executives?

ARCA biopharma's management team includes the following people:

Dr. Michael R. Bristow, Co-Founder, Pres, CEO & Director (Age 75, Pay $296.15k)
Mr. Thomas A. Keuer, Chief Operating Officer (Age 61, Pay $304.02k)
Mr. Christopher D. Ozeroff, Sr. VP, Gen. Counsel & Sec. (Age 61, Pay $290.16k)
Mr. Brian L. Selby, Chief Accounting Officer & VP of Fin. (Age 58)
Dr. Debra Marshall FACC, M.D., Chief Medical Officer

What is ARCA biopharma's stock symbol?

ARCA biopharma trades on the NASDAQ under the ticker symbol "ABIO."

How do I buy shares of ARCA biopharma?

Shares of ABIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ARCA biopharma's stock price today?

One share of ABIO stock can currently be purchased for approximately $4.45.

How big of a company is ARCA biopharma?

ARCA biopharma has a market capitalization of $41.47 million. ARCA biopharma employs 13 workers across the globe.

What is ARCA biopharma's official website?

The official website for ARCA biopharma is arcabio.com.

How can I contact ARCA biopharma?

ARCA biopharma's mailing address is 11080 CIRCLEPOINT ROAD SUITE 140, WESTMINSTER CO, 80020. The biopharmaceutical company can be reached via phone at 720-940-2200 or via email at [email protected]

This page was last updated on 1/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here